Latest On PAVmed Inc (PAVM):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-17 20:40 EST | News | PAVmed (PAVM) Q1 2023 Earnings Call Transcript | N/A |  |
| 2023-05-16 17:27 EST | News | PAVmed Non-GAAP EPS of -$0.10 beats by $0.07, revenue of $0.45M beats by $0.22M | N/A | |
| 2023-03-15 15:12 EST | News | PAVmed Non-GAAP EPS of -$0.15 beats by $0.04, revenue of $112M beats by $111.32M | N/A | |
| 2023-03-15 15:12 EST | News | PAVmed stock dips as net loss widens, revenue shrinks in Q4 | N/A | |
| 2023-03-15 15:12 EST | News | PAVmed Inc. 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-03-15 15:12 EST | News | PAVmed Inc. (PAVM) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-14 08:26 EST | News | PAVmed Q4 2022 Earnings Preview | N/A | |
| 2023-01-17 23:01 EST | News | PAVmed, its units Lucid Diagnostics, Veris Health implement strategic changes, layoffs | N/A | |
| 2022-12-15 14:01 EST | News | PAVmed Digital Health subsidiary launches Veris cancer care platform | N/A | |
| 2022-11-15 23:25 EST | News | PAVmed GAAP EPS of -$0.29 | N/A | |
| 2022-11-15 23:25 EST | News | PAVmed Inc. (PAVM) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-15 06:12 EST | News | PAVmed Q3 2022 Earnings Preview | N/A | |
| 2022-08-17 22:45 EST | News | PAVmed extends losses despite Q2 earnings beat | N/A | |
| 2022-08-17 05:22 EST | News | PAVmed Non-GAAP EPS of -$0.17 beats by $0.03 | N/A | |
| 2022-08-17 05:22 EST | News | PAVmed Inc. (PAVM) CEO Lishan Aklog on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-15 19:53 EST | News | PAVmed Q2 2022 Earnings Preview | N/A | |
| 2022-08-13 15:46 EST | News | Stocks To Watch: Game Time For Walmart, Target, Lowe's And FuboTV | N/A | |
| 2022-07-05 17:55 EST | News | PAVmed Continues To Have Lots Of Potential But EsoGuard Determines Short-Term Progress | N/A | |
| 2022-05-12 22:48 EST | News | PAVmed Non-GAAP EPS of -$0.14 beats by $0.05, revenue of $0.2M misses by $0.15M | N/A | |
| 2022-05-12 22:47 EST | News | PAVmed Inc.'s (PAVM) CEO Lishan Aklog on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-12 03:14 EST | News | PAVmed Q1 2022 Earnings Preview | N/A | |
| 2022-03-30 05:37 EST | News | PAVmed Non-GAAP EPS of -$0.15, revenue of $300M | N/A | |
| 2022-03-30 05:36 EST | News | PAVmed Inc. (PAVM) CEO Lishan Aklog on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-29 07:31 EST | News | PAVmed Q4 2021 Earnings Preview | N/A | |
| 2022-03-24 20:21 EST | News | PAVmed-Lucid esophageal precancer detection test in DOD funded study | N/A | |
| 2022-03-23 09:33 EST | News | Lucid Diagnostics launches test centers in 3 states | N/A | |
| 2022-03-17 18:29 EST | News | PAVmed announces first human implants with the PortIO infusion system | N/A | |
| 2022-03-03 15:56 EST | News | PAVmed unit Lucid acquires certain licenses/assets to operate new lab for EsoGuard test | N/A | |
| 2022-02-24 17:01 EST | News | PAVmed picks internal candidate for COO role | N/A | |
| 2021-12-24 13:45 EST | News | Start Accumulating PAVmed | N/A | |
| 2021-12-22 22:08 EST | News | PAVmed falls 14% following $275M mixed shelf offering | N/A | |
| 2021-11-22 07:43 EST | News | Warning: PAVM is at high risk of performing badly | N/A | |
| 2021-11-17 01:46 EST | News | PAVmed lags consensus with early revenue estimates for Q3 | N/A | |
| 2021-11-17 01:46 EST | News | PAVmed EPS in-line, misses on revenue | N/A | |
| 2021-11-17 01:46 EST | News | PAVmed down 10% after-hours on quarterly earnings | N/A | |
| 2021-11-17 01:46 EST | News | PAVmed Inc. (PAVM) CEO Lishan Aklog on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-07 16:42 EST | News | PAVmed acquires EsophaCap manufacturer, CapNostics | N/A | |
| 2021-09-24 10:57 EST | News | PAVmed Subsidiary, Lucid Diagnostics files IPO, terms undisclosed | N/A | |
| 2021-09-22 02:59 EST | News | PAVmed Inc. (PAVM) 5th Annual Best Ideas Growth (BIG5) Conference Presentation - Slideshow | N/A | |
| 2021-08-23 13:22 EST | News | PAVmed: Long Term Investment Case Remains Despite Weak Q2 | N/A | |
| 2021-08-13 18:46 EST | News | PAVmed Inc. (PAVM) CEO Lishan Aklog on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-13 18:45 EST | News | PAVmed sinks after Q2 revenue lagged estimates | N/A | |
| 2021-07-23 04:39 EST | News | Lucid Diagnostics inks strategic partnership with UpScriptHealth | N/A | |
| 2021-07-21 19:08 EST | News | PAVmed gets European CE Mark for Carpx minimally invasive carpal tunnel device | N/A | |
| 2021-07-21 19:08 EST | News | PAVmed's subsidiary receives CE mark for EsoCheck esophageal cell collection device | N/A | |
| 2021-07-21 19:06 EST | News | PAVmed forms digital health company, Veris Health | N/A | |
| 2021-07-21 19:01 EST | News | PAVmed: A True Game-Changer For Medical Device Innovation | N/A | |
| 2021-03-18 05:29 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-09 02:34 EST | News | PAVmed Primed To Deliver Significant Value For Shareholders | N/A | |
| 2021-02-26 05:23 EST | News | PAVmed closes $45M capital raise | N/A | |
About PAVmed Inc (PAVM):
PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.
General
- Name PAVmed Inc
- Symbol PAVM
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 21
- Fiscal Year EndDecember
- IPO Date2016-04-28
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://www.pavmed.com
View More
Valuation
- Price/Book (Most Recent Quarter) 17.73
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.41
- Next Year EPS Estimate -$0.27
- Next Quarter EPS Estimate -$0.12
- Return on Assets -108%
- Earnings Per Share -$0.65
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 377.67 million
- EBITDA -12330859
- PE Ratio -0.27
- Analyst Target Price $7.42
- Book Value Per Share -$0.11
View More
Share Statistics
- Shares Outstanding 82.46 million
- Shares Float 72.23 million
- % Held by Insiders 1610%
- % Held by Institutions 10.83%
- Shares Short 5.57 million
- Shares Short Prior Month 5.23 million
- Short Ratio 0.9
- Short % of Float 7%
- Short % of Shares Outstanding 7%
View More
Technicals
- Beta 0.29
- 52 Week High $5.63
- 52 Week Low $1.34
- 50 Day Moving Average 3.59
- 200 Day Moving Average 2.36
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
PAVmed Inc (PAVM) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
PAVmed Inc (PAVM) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-22 | $N/A | -$0.17 | -$0.11 | -54.55% |
| 2020-09-30 | 2020-11-06 | $N/A | -$0.11 | -$0.11 | -3.09% |
| 2020-06-30 | 2020-08-14 | $N/A | -$0.13 | -$0.11 | -18.18% |
| 2020-03-31 | 2020-04-09 | $N/A | -$0.19 | -$0.11 | -72.73% |
| 2019-12-31 | 2019-12-31 | $N/A | -$0.19 | -$0.11 | -72.73% |
| 2019-09-30 | 2019-11-19 | $N/A | -$0.10 | -$0.10 | 0% |
| 2019-06-30 | 2019-08-14 | $N/A | -$0.13 | -$0.13 | 0% |
| 2019-03-31 | 2019-05-15 | $N/A | -$0.13 | -$0.13 | 0% |
| 2018-12-31 | 2018-12-31 | $N/A | -$0.15 | -$0.14 | -7.14% |
| 2018-09-30 | 2018-11-14 | $N/A | -$0.12 | -$0.12 | 0% |
| 2018-06-30 | 2018-08-13 | $N/A | -$0.26 | -$0.11 | -136.36% |
| 2018-03-31 | 2018-05-21 | $N/A | -$0.21 | -$0.15 | -40% |
| 2017-09-30 | 2017-11-14 | $N/A | -$0.40 | -$0.16 | -150% |
| 2017-06-30 | 2017-08-11 | $N/A | -$0.08 | -$0.14 | 42.86% |
| 2017-03-31 | 2017-05-22 | $N/A | -$0.14 | -$0.14 | 0% |
| 2016-12-31 | 2017-02-16 | $N/A | -$0.13 | -$0.14 | 7.14% |
| 2016-09-30 | 2016-11-10 | $N/A | -$0.14 | -$0.15 | 6.67% |
| 2016-06-30 | 2016-08-12 | $N/A | -$0.10 | -$0.09 | -11.11% |
PAVmed Inc (PAVM) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
PAVmed Inc (PAVM) Chart:
PAVmed Inc (PAVM) News:
Below you will find a list of latest news for PAVmed Inc (PAVM) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
PAVmed Inc (PAVM) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0.07 | CALL | 0 | 62 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 118.03 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 328.58 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 258.56 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.35 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0.22 | CALL | 0 | 11 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0.05 | CALL | 0 | 6 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.67 | PUT | 0 | 4 | 127.54 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 3.02 | PUT | 0 | 1 | 294.95 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 481.87 | TRUE | 0 | 0 |
| 2024-09-20 | 2.5 | 1.33 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 5 | 0.35 | CALL | 0 | 52 | 123.19 | FALSE | 0 | 0 |
| 2024-09-20 | 7.5 | 0.05 | CALL | 3 | 7 | 123.98 | FALSE | 0 | 0 |
| 2024-09-20 | 2.5 | 1.03 | PUT | 0 | 3 | 132.68 | TRUE | 0 | 0 |
| 2024-09-20 | 5 | 0 | PUT | 0 | 0 | 150.79 | TRUE | 0 | 0 |
| 2024-09-20 | 7.5 | 0 | PUT | 0 | 0 | 244.31 | TRUE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | CALL | 0 | 0 | 149.75 | FALSE | 0 | 0 |
| 2024-12-20 | 5 | 0 | CALL | 0 | 0 | 121.87 | FALSE | 0 | 0 |
| 2024-12-20 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | PUT | 0 | 0 | 137.8 | TRUE | 0 | 0 |
| 2024-12-20 | 5 | 0 | PUT | 0 | 0 | 103.14 | TRUE | 0 | 0 |
| 2024-12-20 | 7.5 | 0 | PUT | 0 | 0 | 156.23 | TRUE | 0 | 0 |
Latest PAVM Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 66 | $0.9372 |
| Jun 13, 2022 7:59 PM EST | 62 | $0.9372 |
| Jun 13, 2022 7:59 PM EST | 400 | $0.9372 |
| Jun 13, 2022 7:59 PM EST | 15 | $0.9372 |
| Jun 13, 2022 7:59 PM EST | 100 | $0.9372 |
PAVmed Inc (PAVM) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220011323/0001493152-20-011323-index.htm |
| 2018-10-12 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1624326/000000000018032181/0000000000-18-032181-index.htm |
| 2019-09-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1624326/000000000019013984/0000000000-19-013984-index.htm |
| 2019-10-03 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1624326/000000000019014244/0000000000-19-014244-index.htm |
| 2019-12-19 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1624326/000000000019016593/0000000000-19-016593-index.htm |
| 2020-01-22 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1624326/000000000020000555/0000000000-20-000555-index.htm |
| 2020-02-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1624326/000000000020001503/0000000000-20-001503-index.htm |
| 2020-09-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1624326/000000000020008631/0000000000-20-008631-index.htm |
| 2018-06-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1624326/000101143818000148/0001011438-18-000148-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1624326/000101143819000063/0001011438-19-000063-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1624326/000101143820000095/0001011438-20-000095-index.htm |
| 2018-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489118000152/0001094891-18-000152-index.htm |
| 2018-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489118000154/0001094891-18-000154-index.htm |
| 2018-07-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489118000156/0001094891-18-000156-index.htm |
| 2018-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489118000164/0001094891-18-000164-index.htm |
| 2019-02-04 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000046/0001094891-19-000046-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000084/0001094891-19-000084-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000085/0001094891-19-000085-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000086/0001094891-19-000086-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000087/0001094891-19-000087-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000088/0001094891-19-000088-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000089/0001094891-19-000089-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000092/0001094891-19-000092-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000093/0001094891-19-000093-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000121/0001094891-19-000121-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000123/0001094891-19-000123-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489120000065/0001094891-20-000065-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489120000066/0001094891-20-000066-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489120000068/0001094891-20-000068-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489120000070/0001094891-20-000070-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489120000074/0001094891-20-000074-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489120000076/0001094891-20-000076-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489120000078/0001094891-20-000078-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000109489120000080/0001094891-20-000080-index.htm |
| 2018-06-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000114036118029763/0001140361-18-029763-index.htm |
| 2018-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000114420418032917/0001144204-18-032917-index.htm |
| 2018-06-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1624326/000114420418033787/0001144204-18-033787-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000114420418033789/0001144204-18-033789-index.htm |
| 2018-07-06 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1624326/000114420418037575/0001144204-18-037575-index.htm |
| 2018-05-24 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315218007732/0001493152-18-007732-index.htm |
| 2018-06-01 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315218008104/0001493152-18-008104-index.htm |
| 2018-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315218008404/0001493152-18-008404-index.htm |
| 2018-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315218008524/0001493152-18-008524-index.htm |
| 2018-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315218009312/0001493152-18-009312-index.htm |
| 2018-07-06 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1624326/000149315218009778/0001493152-18-009778-index.htm |
| 2018-08-10 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1624326/000149315218011391/0001493152-18-011391-index.htm |
| 2018-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315218011526/0001493152-18-011526-index.htm |
| 2018-08-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315218012480/0001493152-18-012480-index.htm |
| 2018-08-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1624326/000149315218012541/0001493152-18-012541-index.htm |
| 2018-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315218014004/0001493152-18-014004-index.htm |
| 2018-10-05 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1624326/000149315218014163/0001493152-18-014163-index.htm |
| 2018-10-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1624326/000149315218014478/0001493152-18-014478-index.htm |
| 2018-10-18 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315218014598/0001493152-18-014598-index.htm |
| 2018-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315218016081/0001493152-18-016081-index.htm |
| 2018-12-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315218018004/0001493152-18-018004-index.htm |
| 2019-01-09 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1624326/000149315219000337/0001493152-19-000337-index.htm |
| 2019-01-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219000455/0001493152-19-000455-index.htm |
| 2019-01-25 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1624326/000149315219000959/0001493152-19-000959-index.htm |
| 2019-02-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219002077/0001493152-19-002077-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219003192/0001493152-19-003192-index.htm |
| 2019-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219003615/0001493152-19-003615-index.htm |
| 2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219004603/0001493152-19-004603-index.htm |
| 2019-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219005118/0001493152-19-005118-index.htm |
| 2019-04-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219005217/0001493152-19-005217-index.htm |
| 2019-04-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219005247/0001493152-19-005247-index.htm |
| 2019-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219005466/0001493152-19-005466-index.htm |
| 2019-04-19 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1624326/000149315219005667/0001493152-19-005667-index.htm |
| 2019-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219005816/0001493152-19-005816-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1624326/000149315219006165/0001493152-19-006165-index.htm |
| 2019-05-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219006561/0001493152-19-006561-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219006562/0001493152-19-006562-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219007219/0001493152-19-007219-index.htm |
| 2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219007446/0001493152-19-007446-index.htm |
| 2019-05-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1624326/000149315219007777/0001493152-19-007777-index.htm |
| 2019-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219007884/0001493152-19-007884-index.htm |
| 2019-05-22 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1624326/000149315219008077/0001493152-19-008077-index.htm |
| 2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219008789/0001493152-19-008789-index.htm |
| 2019-06-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219009664/0001493152-19-009664-index.htm |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219009665/0001493152-19-009665-index.htm |
| 2019-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219009776/0001493152-19-009776-index.htm |
| 2019-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219010639/0001493152-19-010639-index.htm |
| 2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219012534/0001493152-19-012534-index.htm |
| 2019-09-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1624326/000149315219014758/0001493152-19-014758-index.htm |
| 2019-09-30 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219014761/0001493152-19-014761-index.htm |
| 2019-09-30 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219014763/0001493152-19-014763-index.htm |
| 2019-09-30 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219014768/0001493152-19-014768-index.htm |
| 2019-10-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219015418/0001493152-19-015418-index.htm |
| 2019-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315219016387/0001493152-19-016387-index.htm |
| 2019-11-07 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1624326/000149315219016564/0001493152-19-016564-index.htm |
| 2019-11-15 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1624326/000149315219017676/0001493152-19-017676-index.htm |
| 2019-11-19 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315219017989/0001493152-19-017989-index.htm |
| 2019-12-03 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1624326/000149315219018681/0001493152-19-018681-index.htm |
| 2019-12-05 | DEL AM | Delaying amendment | https://www.sec.gov/Archives/edgar/data/1624326/000149315219018779/0001493152-19-018779-index.htm |
| 2020-01-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1624326/000149315220000374/0001493152-20-000374-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220000502/0001493152-20-000502-index.htm |
| 2020-01-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1624326/000149315220001396/0001493152-20-001396-index.htm |
| 2020-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220001909/0001493152-20-001909-index.htm |
| 2020-02-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220002639/0001493152-20-002639-index.htm |
| 2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220002766/0001493152-20-002766-index.htm |
| 2020-03-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220003191/0001493152-20-003191-index.htm |
| 2020-03-02 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1624326/000149315220003240/0001493152-20-003240-index.htm |
| 2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220003574/0001493152-20-003574-index.htm |
| 2020-03-30 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/1624326/000149315220005214/0001493152-20-005214-index.htm |
| 2020-03-30 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1624326/000149315220005215/0001493152-20-005215-index.htm |
| 2020-03-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220005413/0001493152-20-005413-index.htm |
| 2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220005660/0001493152-20-005660-index.htm |
| 2020-04-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220006143/0001493152-20-006143-index.htm |
| 2020-04-14 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1624326/000149315220006405/0001493152-20-006405-index.htm |
| 2020-04-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1624326/000149315220006461/0001493152-20-006461-index.htm |
| 2020-04-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1624326/000149315220006775/0001493152-20-006775-index.htm |
| 2020-04-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220006812/0001493152-20-006812-index.htm |
| 2020-04-24 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1624326/000149315220007055/0001493152-20-007055-index.htm |
| 2020-04-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1624326/000149315220007062/0001493152-20-007062-index.htm |
| 2020-04-28 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315220007262/0001493152-20-007262-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220007500/0001493152-20-007500-index.htm |
| 2020-05-01 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1624326/000149315220007538/0001493152-20-007538-index.htm |
| 2020-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220008906/0001493152-20-008906-index.htm |
| 2020-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220009636/0001493152-20-009636-index.htm |
| 2020-05-28 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315220010040/0001493152-20-010040-index.htm |
| 2020-06-01 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1624326/000149315220010217/0001493152-20-010217-index.htm |
| 2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220010441/0001493152-20-010441-index.htm |
| 2020-06-11 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1624326/000149315220010973/0001493152-20-010973-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220010975/0001493152-20-010975-index.htm |
| 2020-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220011169/0001493152-20-011169-index.htm |
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220011323/0001493152-20-011323-index.htm |
| 2020-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220014017/0001493152-20-014017-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220014823/0001493152-20-014823-index.htm |
| 2020-08-11 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1624326/000149315220015224/0001493152-20-015224-index.htm |
| 2020-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315220015956/0001493152-20-015956-index.htm |
| 2020-08-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1624326/000149315220016201/0001493152-20-016201-index.htm |
| 2020-09-01 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1624326/000149315220017094/0001493152-20-017094-index.htm |
| 2020-09-10 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1624326/000149315220017563/0001493152-20-017563-index.htm |
| 2020-09-14 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1624326/000149315220017745/0001493152-20-017745-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1624326/000149315220020703/0001493152-20-020703-index.htm |
| 2018-06-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1624326/000153561018000092/0001535610-18-000092-index.htm |
| 2019-01-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1624326/000153561019000038/0001535610-19-000038-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000156761919001732/0001567619-19-001732-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000156761920001925/0001567619-20-001925-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1624326/000156761920011404/0001567619-20-011404-index.htm |
| 2018-05-23 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1624326/999999999518001315/9999999995-18-001315-index.htm |
| 2018-10-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1624326/999999999518002651/9999999995-18-002651-index.htm |
| 2020-04-28 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1624326/999999999520000896/9999999995-20-000896-index.htm |
| 2020-09-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1624326/999999999520002492/9999999995-20-002492-index.htm |
PAVmed Inc (PAVM) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PAVmed Inc (PAVM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1610%Institutional Ownership: 1083%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-04-30 | Lishan Aklog | Chairman and CEO | Buy | 250,000.00 | 1,098,413.00 | https://www.sec.gov/Archives/edgar/data/1624326/000109489120000066/0001094891-20-000066-index.htm | ||
| 2020-05-29 | MATTHEW SIROVICH | 10% Share Holder | Sell | 131,082.00 | 1.98 | 259,476.82 | 1,213,983.00 | https://www.sec.gov/Archives/edgar/data/1624326/000156761920011404/0001567619-20-011404-index.htm |
| 2020-05-28 | MATTHEW SIROVICH | 10% Share Holder | Sell | 69,839.00 | 2.06 | 143,665.81 | 1,345,065.00 | https://www.sec.gov/Archives/edgar/data/1624326/000156761920011404/0001567619-20-011404-index.htm |
| 2018-06-08 | Ira Scott Greenspan | 10% Share Holder | Sell | 18,300.00 | 1.04 | 19,032.00 | 421,691.00 | https://www.sec.gov/Archives/edgar/data/1624326/000114420418033789/0001144204-18-033789-index.htm |
| 2018-06-01 | Ira Scott Greenspan | 10% Share Holder | Sell | 532,255.00 | 0.97 | 516,287.35 | 439,991.00 | https://www.sec.gov/Archives/edgar/data/1624326/000114420418032917/0001144204-18-032917-index.htm |
| 2019-03-15 | DENNIS M MCGRATH | EVP & CFO | Buy | 500,000.00 | 524,000.00 | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000092/0001094891-19-000092-index.htm | ||
| 2019-05-24 | DENNIS M MCGRATH | President & CFO | Buy | 5,000.00 | 1.09 | 5,428.50 | 529,000.00 | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000123/0001094891-19-000123-index.htm |
| 2018-08-28 | Lishan Aklog | Chairman and CEO | Buy | 30,000.00 | 1.18 | 35,400.00 | 618,413.00 | https://www.sec.gov/Archives/edgar/data/1624326/000109489118000164/0001094891-18-000164-index.htm |
| 2020-04-30 | DENNIS M MCGRATH | President & CFO | Buy | 250,000.00 | 791,704.00 | https://www.sec.gov/Archives/edgar/data/1624326/000109489120000065/0001094891-20-000065-index.htm | ||
| 2019-03-15 | Lishan Aklog | Chairman and CEO | Buy | 200,000.00 | 818,413.00 | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000093/0001094891-19-000093-index.htm | ||
| 2019-05-23 | Lishan Aklog | Chairman and CEO | Buy | 30,000.00 | 1.10 | 32,850.00 | 848,413.00 | https://www.sec.gov/Archives/edgar/data/1624326/000109489119000121/0001094891-19-000121-index.htm |